Whitehawk Therapeutics to participate in Piper Sandler Healthcare Conference fireside chat.
ByAinvest
Wednesday, Nov 26, 2025 8:08 am ET1min read
WHWK--
Whitehawk Therapeutics, an oncology therapeutics company, announced that Dave Lennon, PhD, President and CEO, will participate in a fireside discussion at the Piper Sandler 37th Annual Healthcare Conference on December 3, 2025. A live webcast of the discussion will be available on Whitehawk's IR website and will be replayable for 30 days. The company's advanced three-asset antibody drug conjugate portfolio aims to overcome limitations of first-generation predecessors to deliver improved cancer treatments.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet